FCG
VRTX icon

Fielder Capital Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Fielder Capital Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Sell
499
-77
-13% -$34.1K 0.05% 255
2026
Q1 		$257K Buy
576
+124
+27% +$57.8K 0.06% 225
2025
Q4 		$205K Buy
+452
New +$195K 0.04% 263
2025
Q3 		– Sell
-553
Closed -$246K – 279
2025
Q2 		$246K Buy
553
+20
+4% +$9.22K 0.07% 190
2025
Q1 		$258K Buy
+533
New +$248K 0.07% 169

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fielder Capital Group's VRTX Position: Q2 2026 in Review

Fielder Capital Group reduced its Vertex Pharmaceuticals (VRTX) stake by 13% in Q2 2026, selling an estimated $34.1K and leaving 499 shares worth $248K. The position accounts for 0.05% of the portfolio, ranked #255.

Fielder Capital Group first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $258K in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Fielder Capital Group held 499 shares of Vertex Pharmaceuticals worth $248K as of Q2 2026.
  • Fielder Capital Group sold 77 Vertex Pharmaceuticals shares in Q2 2026, an estimated $34.1K.
  • Vertex Pharmaceuticals made up 0.05% of Fielder Capital Group's portfolio in Q2 2026, its #255 holding.
  • Fielder Capital Group first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Fielder Capital Group's Vertex Pharmaceuticals position peaked at $258K in Q1 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Fielder Capital Group's 13F filing for Q2 2026, filed 6 Aug 2026.